Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Real-Time Data. Real-World Impact.
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Covance has been selected as a finalist in two categories for the Scrip Awards 2018
Best Technological Development in Clinical Trials - Clinical Sponsor-focused category in the Scrip Awards 2018 Best Contract Research Organization – Full-Service Providers
Leveraging Deep Experience to Support a Combination Antibiotic Clinical Trial
Learn how Covance leveraged past experience to handle challenges with study start up, patient enrollment and sample processing for this complex study.
Enhancing Study Design with a Real World Evidence Tool
Real World Evidence (RWE) has the potential to transform our industry, but there are a number of challenges when it comes to planning a study and execution. Learn about a powerful new tool that can help improve your RWE study design and register for our webinar today.
Driving Clinical Transformation through a Next Generation of Data Integration & Analytic Technologies with GSK/Covance
Register for the upcoming webinar to learn about a case study from GSK and Covance that will be held on November 28.
Have you visited the NASH Education Center?
We’re pleased to announce the launch of the NASH Education Center. Access the latest thoughts from experts through webinars, case studies, blogs, info sheets and scientific articles.
Solutions to minimize risk and optimize your trial designs
Discover how our innovation, commitment and expertise can accelerate your complex immuno-oncology drug development
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Access the latest in scientific and patient centric solutions for your Rare Disease and Orphan Drug Development Program
Drug-Drug Interactions | Monday, December 17, 11:00 am EST
Join Josh Fohey and Dan Albaugh on Monday, December 17, as they share how Covance is coupling industry-leading in vitro and in vivo experiments with an FDA recognized in silico approach called "physiologically based pharmacokinetic (PBPK) modeling." The webinar will also review FDA regulatory guidance and present case studies, demonstrating the use of PBPK models. Learn more >
Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Immuno-oncology and the role of biomarkers, companion and complementary diagnostics
Learn more about how the use of a variety of biomarkers, companion diagnostics (CDx) and complementary diagnostics has powered the recent evolution of immunotherapies and their potential applications.
Covance leads the way in CMC analytical testing capabilities and solutions, helping you to identify, assess and demonstrate control over your biologic’s Critical Quality Attributes.
Access the latest scientific posters, blogs, info sheets and service profiles
Immuno-oncology education center
Learn about the latest advances in immuno-oncology. Download webinars, white papers, case studies and blogs.